Harmony Biosciences Holdings, Inc. (HRMY)
29.40
-0.58
(-1.95%)
USD |
NASDAQ |
Apr 20, 12:55
Harmony Biosciences Holdings SG&A Expense (Quarterly) : 86.74M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Castle Biosciences, Inc. | 56.73M |
| BioMarin Pharmaceutical, Inc. | 446.21M |
| Amicus Therapeutics, Inc. | 117.08M |
| Iovance Biotherapeutics, Inc. | 36.40M |
| Apellis Pharmaceuticals, Inc. | 147.10M |